NorthRock Partners’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $61.4K | Sell |
740
-63
| -8% | -$5.22K | ﹤0.01% | 752 |
|
|
2025
Q1 | $65.1K | Buy |
803
+100
| +14% | +$8.11K | ﹤0.01% | 661 |
|
|
2024
Q4 | $63.3K | Sell |
703
-155
| -18% | -$14K | ﹤0.01% | 638 |
|
|
2024
Q3 | $84.7K | Buy |
858
+10
| +1% | +$988 | ﹤0.01% | 663 |
|
|
2024
Q2 | $78.6K | Sell |
848
-56
| -6% | -$5.19K | ﹤0.01% | 633 |
|
|
2024
Q1 | $85.8K | Buy |
904
+749
| +483% | +$71.1K | ﹤0.01% | 632 |
|
|
2023
Q4 | $13.8K | Buy |
+155
| New | +$13.8K | ﹤0.01% | 665 |
|